Vertex Pharmaceuticals Incorporated (VRTX) Presents at Morgan Stanley 23rd Annual Global

Core Insights - Vertex Pharmaceuticals is being presented by Morgan Stanley's U.S. biopharma analyst, Terence Flynn, indicating a focus on the biopharmaceutical sector [1] - The session includes opening remarks from the company's CEO and President, Reshma Kewalramani, followed by a Q&A segment [2]